These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 39404382)
1. The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut. Brown K; Funk K; Figueroa Barrientos A; Bailey A; Shrader S; Feng W; McClain CJ; Song ZH Cells; 2024 Sep; 13(19):. PubMed ID: 39404382 [TBL] [Abstract][Full Text] [Related]
2. Cannabinoids and the Microbiota-Gut-Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders. Karoly HC; Mueller RL; Bidwell LC; Hutchison KE Alcohol Clin Exp Res; 2020 Feb; 44(2):340-353. PubMed ID: 31803950 [TBL] [Abstract][Full Text] [Related]
3. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922 [TBL] [Abstract][Full Text] [Related]
4. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of CBD in Autism Spectrum Disorder. Pedrazzi JFC; Hassib L; Ferreira FR; Hallak JC; Del-Bel E; Crippa JA Int Rev Neurobiol; 2024; 177():149-203. PubMed ID: 39029984 [TBL] [Abstract][Full Text] [Related]
6. Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract. Skinner CM; Nookaew I; Ewing LE; Wongsurawat T; Jenjaroenpun P; Quick CM; Yee EU; Piccolo BD; ElSohly M; Walker LA; Gurley B; Koturbash I J Diet Suppl; 2020; 17(5):543-560. PubMed ID: 32400224 [TBL] [Abstract][Full Text] [Related]
7. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids. Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166 [TBL] [Abstract][Full Text] [Related]
8. Molecular and Cellular Mechanisms of Action of Cannabidiol. Martinez Naya N; Kelly J; Corna G; Golino M; Abbate A; Toldo S Molecules; 2023 Aug; 28(16):. PubMed ID: 37630232 [TBL] [Abstract][Full Text] [Related]
9. A Critical Review of the Role of the Cannabinoid Compounds Δ Jones É; Vlachou S Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776 [TBL] [Abstract][Full Text] [Related]
10. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial. Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161 [TBL] [Abstract][Full Text] [Related]
11. Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol. Černe K Arh Hig Rada Toksikol; 2020 Mar; 71(1):1-11. PubMed ID: 32597140 [TBL] [Abstract][Full Text] [Related]